Controlled substance prescription monitoring program;
information; prescription forms
Sec. 8. The advisory committee shall provide for a controlled
substance prescription monitoring program that includes the
following components:
(1) Each time a controlled substance designated by the advisory
committee under IC 35-48-2-5 through IC 35-48-2-10 is
dispensed, the dispenser shall transmit to the central repository
the following information:
(A) The recipient's name.
(B) The recipient's or the recipient representative's
identification number or the identification number or phrase
designated by the central repository.
(C) The recipient's date of birth.
(D) The national drug code number of the controlled
substance dispensed.
(E) The date the controlled substance is dispensed.
(F) The quantity of the controlled substance dispensed.
(G) The number of days of supply dispensed.
(H) The dispenser's United States Drug Enforcement Agency
registration number.
(I) The prescriber's United States Drug Enforcement Agency
registration number.
(J) An indication as to whether the prescription was
transmitted to the pharmacist orally or in writing.
(2) The information required to be transmitted under this
section must be transmitted not more than fifteen (15) days after
the date on which a controlled substance is dispensed.
(3) A dispenser shall transmit the information required under
this section by:
(A) an electronic device compatible with the receiving
device of the central repository;
(B) a computer diskette;
(C) a magnetic tape; or
(D) a pharmacy universal claim form;
that meets specifications prescribed by the advisory committee.
(4) The advisory committee may require that prescriptions for
controlled substances be written on a one (1) part form that
cannot be duplicated. However, the advisory committee may not
apply such a requirement to prescriptions filled at a pharmacy
with a Type II permit (as described in IC 25-26-13-17) and
operated by a hospital licensed under IC 16-21, or prescriptions
ordered for and dispensed to bona fide enrolled patients in
facilities licensed under IC 16-28. The committee may not
require multiple copy prescription forms and serially numbered
prescription forms for any prescriptions written. The committee
may not require different prescription forms for any individual
drug or group of drugs. Prescription forms required under this
subdivision must be jointly approved by the committee and by
the Indiana board of pharmacy established by IC 25-26-13-3.
(5) The costs of the program.
As added by P.L.163-1994, SEC.5. Amended by P.L.107-1999,
SEC.2; P.L.182-2003, SEC.6; P.L.204-2005, SEC.23.
Last modified: May 24, 2006